Management of Angiomyolipomas

Surveillance and Monitoring

The American College of Radiology recommends ultrasound surveillance every 3 years for small AMLs (<4 cm), as spontaneous hemorrhage risk is very low 1, 2, 3
For medium AMLs (4-6 cm), increase monitoring frequency to every 6-12 months using MRI or CT, considering intervention if growth rate exceeds 0.5 cm/year 1, 2, 3
The National Institute of Health suggests MRI or CT surveillance every 6 months for large AMLs (>6 cm) due to substantially higher bleeding risk 2, 3
More frequent monitoring is warranted for TSC-associated AMLs, regardless of size, as they are larger, more frequently bilateral, and more prone to bleeding 2, 3, 4

Intratumoral aneurysms ≥5 mm dramatically increase bleeding risk and warrant prophylactic treatment consideration 2, 3
Growth rate >0.5 cm/year (or >5 mm/year for fat-poor lesions) indicates higher risk 1, 2, 3
Development of symptoms (flank pain, hematuria) requires immediate reassessment 1, 3

Use the same imaging modality consistently for accurate growth assessment 1, 3
Do not use different imaging modalities interchangeably during surveillance, as measurements vary significantly between ultrasound, CT, and MRI 1, 3